{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:37:43Z","timestamp":1794285463841,"version":"4.9.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,17]],"date-time":"2011-01-17T00:00:00Z","timestamp":1295222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2415-11-1","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T11:14:43Z","timestamp":1295435683000},"source":"Crossref","is-referenced-by-count":20,"title":["ISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol"],"prefix":"10.1186","volume":"11","author":[{"given":"Frank","family":"Bochmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph N","family":"Becht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Guber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas M","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,17]]},"reference":[{"issue":"4","key":"192_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0002-9394(68)91288-9","volume":"66","author":"JE Cairns","year":"1968","unstructured":"Cairns JE: Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol. 1968, 66 (4): 673-679.","journal-title":"Am J Ophthalmol"},{"key":"192_CR2","doi-asserted-by":"crossref","unstructured":"Five-year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group. Am J Ophthalmol. 1996, 121 (4): 349-366.","DOI":"10.1016\/S0002-9394(14)70431-3"},{"issue":"2","key":"192_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00417-002-0621-5","volume":"241","author":"HJ Beckers","year":"2003","unstructured":"Beckers HJ, Kinders KC, Webers CA: Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol. 2003, 241 (2): 106-110. 10.1007\/s00417-002-0621-5.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"192_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s004170050349","volume":"238","author":"Y Hagiwara","year":"2000","unstructured":"Hagiwara Y, Yamamoto T, Kitazawa Y: The effect of mitomycin C trabeculectomy on the progression of visual field defect in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2000, 238 (3): 232-236. 10.1007\/s004170050349.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"192_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0002-9394(98)00279-7","volume":"126","author":"YY Kim","year":"1998","unstructured":"Kim YY, Sexton RM, Shin DH, Kim C, Ginde SA, Ren J, Lee D, Kupin TH: Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C. Am J Ophthalmol. 1998, 126 (6): 755-762. 10.1016\/S0002-9394(98)00279-7.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"192_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/BF00190712","volume":"234","author":"H Mietz","year":"1996","unstructured":"Mietz H, Arnold G, Kirchhof B, Diestelhorst M, Krieglstein GK: Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch Clin Exp Ophthalmol. 1996, 234 (6): 364-368. 10.1007\/BF00190712.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"192_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0002-9394(02)01627-6","volume":"134","author":"D WuDunn","year":"2002","unstructured":"WuDunn D, Cantor LB, Palanca-Capistrano AM, Hoop J, Alvi NP, Finley C, Lakhani V, Burnstein A, Knotts SL: A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy. Am J Ophthalmol. 2002, 134 (4): 521-528. 10.1016\/S0002-9394(02)01627-6.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"192_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0161-6420(92)31721-X","volume":"99","author":"H Ando","year":"1992","unstructured":"Ando H, Ido T, Kawai Y, Yamamoto T, Kitazawa Y: Inhibition of corneal epithelial wound healing. A comparative study of mitomycin C and 5-fluorouracil. Ophthalmology. 1992, 99 (12): 1809-1814.","journal-title":"Ophthalmology"},{"issue":"3","key":"192_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/bjo.2002.007708","volume":"88","author":"JG Crowston","year":"2004","unstructured":"Crowston JG, Chang LH, Daniels JT, Khaw PT, Akbar AN: T lymphocyte mediated lysis of mitomycin C treated Tenon's capsule fibroblasts. Br J Ophthalmol. 2004, 88 (3): 399-405. 10.1136\/bjo.2002.007708.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"192_CR10","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/archopht.124.8.1095","volume":"124","author":"EM Messmer","year":"2006","unstructured":"Messmer EM, Zapp DM, Mackert MJ, Thiel M, Kampik A: In vivo confocal microscopy of filtering blebs after trabeculectomy. Arch Ophthalmol. 2006, 124 (8): 1095-1103. 10.1001\/archopht.124.8.1095.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"192_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1006\/bbrc.1999.1589","volume":"264","author":"J Tran","year":"1999","unstructured":"Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG, Kerbel RS: Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun. 1999, 264 (3): 781-788. 10.1006\/bbrc.1999.1589.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"192_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00403-005-0596-2","volume":"297","author":"M Fujiwara","year":"2005","unstructured":"Fujiwara M, Muragaki Y, Ooshima A: Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res. 2005, 297 (4): 161-169. 10.1007\/s00403-005-0596-2.","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"192_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/sj.jid.5700274","volume":"126","author":"WS Wu","year":"2006","unstructured":"Wu WS, Wang FS, Yang KD, Huang CC, Kuo YR: Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol. 2006, 126 (6): 1264-1271. 10.1038\/sj.jid.5700274.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"192_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.exer.2004.11.006","volume":"80","author":"N Asano-Kato","year":"2005","unstructured":"Asano-Kato N, Fukagawa K, Okada N, Kawakita T, Takano Y, Dogru M, Tsubota K, Fujishima H: TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts. Exp Eye Res. 2005, 80 (4): 555-560. 10.1016\/j.exer.2004.11.006.","journal-title":"Exp Eye Res"},{"issue":"4","key":"192_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1006\/exer.1994.1037","volume":"58","author":"J Wong","year":"1994","unstructured":"Wong J, Wang N, Miller JW, Schuman JS: Modulation of human fibroblast activity by selected angiogenesis inhibitors. Exp Eye Res. 1994, 58 (4): 439-451. 10.1006\/exer.1994.1037.","journal-title":"Exp Eye Res"},{"issue":"Suppl 3","key":"192_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000088481","volume":"69","author":"MS Gordon","year":"2005","unstructured":"Gordon MS, Cunningham D: Managing patients treated with bevacizumab combination therapy. Oncology. 2005, 69 (Suppl 3): 25-33. 10.1159\/000088481.","journal-title":"Oncology"},{"issue":"3","key":"192_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/jso.20301","volume":"91","author":"FA Scappaticci","year":"2005","unstructured":"Scappaticci FA, Fehrenbacher L, Cartwright T, Hainsworth JD, Heim W, Berlin J, Kabbinavar F, Novotny W, Sarkar S, Hurwitz H: Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol. 2005, 91 (3): 173-180. 10.1002\/jso.20301.","journal-title":"J Surg Oncol"},{"issue":"2","key":"192_CR18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3928\/1542-8877-20060301-12","volume":"37","author":"MY Kahook","year":"2006","unstructured":"Kahook MY, Schuman JS, Noecker RJ: Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic Surg Lasers Imaging. 2006, 37 (2): 148-150.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"6","key":"192_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/archopht.125.6.834","volume":"125","author":"JJ DeStafeno","year":"2007","unstructured":"DeStafeno JJ, Kim T: Topical bevacizumab therapy for corneal neovascularization. Arch Ophthalmol. 2007, 125 (6): 834-836. 10.1001\/archopht.125.6.834.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"192_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3928\/1542-8877-20060301-11","volume":"37","author":"MY Kahook","year":"2006","unstructured":"Kahook MY, Schuman JS, Noecker RJ: Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2006, 37 (2): 144-146.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"6","key":"192_CR21","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","volume":"112","author":"S Michels","year":"2005","unstructured":"Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS: Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology. 2005, 112 (6): 1035-1047. 10.1016\/j.ophtha.2005.02.007.","journal-title":"Ophthalmology"},{"issue":"3","key":"192_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00006982-200603000-00001","volume":"26","author":"RP Manzano","year":"2006","unstructured":"Manzano RP, Peyman GA, Khan P, Kivilcim M: Testing intravitreal toxicity of bevacizumab (Avastin). Retina. 2006, 26 (3): 257-261. 10.1097\/00006982-200603000-00001.","journal-title":"Retina"},{"issue":"14","key":"192_CR23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY: Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006, 355 (14): 1419-1431. 10.1056\/NEJMoa054481.","journal-title":"N Engl J Med"},{"issue":"6","key":"192_CR24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ophtha.2005.01.043","volume":"112","author":"PJ Rosenfeld","year":"2005","unstructured":"Rosenfeld PJ, Schwartz SD, Blumenkranz MS, Miller JW, Haller JA, Reimann JD, Greene WL, Shams N: Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology. 2005, 112 (6): 1048-1053. 10.1016\/j.ophtha.2005.01.043.","journal-title":"Ophthalmology"},{"issue":"2","key":"192_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1167\/iovs.04-0601","volume":"46","author":"J Gaudreault","year":"2005","unstructured":"Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V: Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci. 2005, 46 (2): 726-733. 10.1167\/iovs.04-0601.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"192_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0039-6257(98)00025-3","volume":"43","author":"A Azuara-Blanco","year":"1998","unstructured":"Azuara-Blanco A, Katz LJ: Dysfunctional filtering blebs. Surv Ophthalmol. 1998, 43 (2): 93-126. 10.1016\/S0039-6257(98)00025-3.","journal-title":"Surv Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-11-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-11-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-11-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-11-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:02:28Z","timestamp":1548212548000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-11-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,17]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["192"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-11-1","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,17]]},"article-number":"1"}}